Scrub typhus, also known as tsutsugamushi disease, is a bacterial infection classified under the broader category of typhus fevers. The causative agent is *Orientia tsutsugamushi*, an obligate intracellular Gram-negative bacterium that replicates within endothelial cells and macrophages. It is distinct from other typhus forms such as epidemic and murine typhus, which are caused by different rickettsial species (*Rickettsia prowazekii* and *Rickettsia typhi*, respectively). The disease is recognized internationally under ICD-10 code A75.3 and ICD-11 code 1C30.2.
Disease Profile
BacterialScrub Typhus
恙虫病
Scrub typhus is a bacterial zoonotic disease caused by the intracellular pathogen *Orientia tsutsugamushi*, transmitted via bite of infected chiggers (larval mites). It belongs to the typhus group and typically presents with fever, headache, and a rash appearing one to two weeks post-exposure. Endemic in parts of Asia, the Pacific, and northern Australia, it remains underreported in many settings due to diagnostic challenges and limited surveillance capacity.
The clinical syndrome typically manifests after an incubation period of one to two weeks following exposure, with hallmark features including high fever, severe headache, myalgia, and a characteristic eschar at the site of the chigger bite—though this may be overlooked or absent in some cases. A maculopapular rash often develops later in the illness, frequently involving the trunk but sparing the face and palms. Complications may include pneumonia, acute respiratory distress syndrome, encephalitis, and multiorgan failure, particularly in untreated or delayed cases. Severity varies, with case fatality rates reported to range from less than 1% in well-treated patients to over 10% in severe or late-presenting cases; however, precise severity stratification is not available from the provided sources.
Scrub typhus is endemic across a broad geographic belt stretching from the Russian Far East through Southeast Asia, the Indian subcontinent, and into northern Australia. Human infection occurs primarily through contact with vegetation infested by larval trombiculid mites (chiggers), which serve as vectors and maintain the pathogen in rodent reservoirs. Outbreaks are often associated with agricultural or forested areas where human activity increases exposure risk. Surveillance data indicate substantial underdiagnosis and underreporting globally, especially in rural and low-resource regions, though specific burden estimates are not provided in the source snippets.
Transmission occurs exclusively through the bite of infected larval chiggers (the six-legged stage of trombiculid mites), which acquire the organism during feeding on infected rodents. Humans are incidental hosts; no human-to-human transmission has been documented. The pathogen does not persist in the environment outside the vector or reservoir host, and there is no evidence of airborne, fecal-oral, or bloodborne spread. The timing of transmission is closely tied to seasonal patterns of mite activity, typically peaking during warmer months in endemic zones.
Individuals at highest risk include those engaged in outdoor occupations or recreational activities in endemic regions—such as farmers, forestry workers, military personnel, and hikers—particularly during peak chigger season. Children and older adults may experience more severe outcomes, though this is not explicitly supported by the source snippets. No specific demographic or immunological risk factors beyond exposure intensity are described in the available content.
Primary prevention relies on minimizing exposure to chigger-infested environments—particularly through use of protective clothing, insect repellents containing DEET or picaridin, and avoidance of sitting or lying on grassy or brushy ground. Environmental management, including clearing vegetation and reducing rodent habitats, may help mitigate risk in high-incidence areas. No vaccine is currently available for human use, and chemoprophylaxis is not recommended for general populations. Public health interventions should prioritize early diagnosis and appropriate antibiotic therapy in suspected cases.
In surveillance contexts, scrub typhus should be considered in patients presenting with acute febrile illness and a history of recent travel or residence in endemic areas, especially if accompanied by an eschar or unexplained rash. Laboratory confirmation requires serologic testing (e.g., indirect immunofluorescence assay) or molecular methods (PCR), though these are not universally accessible. Due to its non-specific presentation and lack of routine reporting, surveillance systems must rely on targeted case detection and integration with regional vector-borne disease monitoring programs. Source-backed detail on temporal trends, age-specific incidence, or geographic hotspots is not available in the provided materials.
- A75.3
- 1C30.2
Figure 1 | Full historical trajectories across all reporting countries.
Figure 2 | Year-over-year monthly comparison for seasonality and structural shifts.
Dataset Archive
Supplementary Data | Multi-country disease dataset
Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.
Source Register
Official sources and update cadences used to construct the downloadable dataset.
China
Monthly notifiable infectious disease reports published by China CDC.
Official sourceChina
Official China public health bulletin and query portal.
Official sourceChina
Biomedical literature discovery feed used as supplementary context.
Official sourceJapan
Japan weekly infectious disease surveillance via NIID/JIHS.
Official source